QQQ   444.84 (-0.17%)
AAPL   173.99 (-3.16%)
MSFT   415.48 (+0.00%)
META   502.00 (-0.06%)
GOOGL   132.58 (-3.33%)
AMZN   178.13 (-0.05%)
TSLA   187.45 (-7.50%)
NVDA   866.97 (+5.37%)
NIO   5.37 (-7.09%)
AMD   207.63 (+2.46%)
BABA   71.87 (-3.69%)
T   16.83 (-0.88%)
F   12.88 (+3.45%)
MU   96.69 (+1.62%)
CGC   3.01 (-6.23%)
GE   160.35 (+1.07%)
DIS   113.53 (+1.41%)
AMC   4.30 (-1.38%)
PFE   25.91 (-2.56%)
PYPL   59.73 (-1.34%)
XOM   104.30 (-1.46%)
QQQ   444.84 (-0.17%)
AAPL   173.99 (-3.16%)
MSFT   415.48 (+0.00%)
META   502.00 (-0.06%)
GOOGL   132.58 (-3.33%)
AMZN   178.13 (-0.05%)
TSLA   187.45 (-7.50%)
NVDA   866.97 (+5.37%)
NIO   5.37 (-7.09%)
AMD   207.63 (+2.46%)
BABA   71.87 (-3.69%)
T   16.83 (-0.88%)
F   12.88 (+3.45%)
MU   96.69 (+1.62%)
CGC   3.01 (-6.23%)
GE   160.35 (+1.07%)
DIS   113.53 (+1.41%)
AMC   4.30 (-1.38%)
PFE   25.91 (-2.56%)
PYPL   59.73 (-1.34%)
XOM   104.30 (-1.46%)
QQQ   444.84 (-0.17%)
AAPL   173.99 (-3.16%)
MSFT   415.48 (+0.00%)
META   502.00 (-0.06%)
GOOGL   132.58 (-3.33%)
AMZN   178.13 (-0.05%)
TSLA   187.45 (-7.50%)
NVDA   866.97 (+5.37%)
NIO   5.37 (-7.09%)
AMD   207.63 (+2.46%)
BABA   71.87 (-3.69%)
T   16.83 (-0.88%)
F   12.88 (+3.45%)
MU   96.69 (+1.62%)
CGC   3.01 (-6.23%)
GE   160.35 (+1.07%)
DIS   113.53 (+1.41%)
AMC   4.30 (-1.38%)
PFE   25.91 (-2.56%)
PYPL   59.73 (-1.34%)
XOM   104.30 (-1.46%)
QQQ   444.84 (-0.17%)
AAPL   173.99 (-3.16%)
MSFT   415.48 (+0.00%)
META   502.00 (-0.06%)
GOOGL   132.58 (-3.33%)
AMZN   178.13 (-0.05%)
TSLA   187.45 (-7.50%)
NVDA   866.97 (+5.37%)
NIO   5.37 (-7.09%)
AMD   207.63 (+2.46%)
BABA   71.87 (-3.69%)
T   16.83 (-0.88%)
F   12.88 (+3.45%)
MU   96.69 (+1.62%)
CGC   3.01 (-6.23%)
GE   160.35 (+1.07%)
DIS   113.53 (+1.41%)
AMC   4.30 (-1.38%)
PFE   25.91 (-2.56%)
PYPL   59.73 (-1.34%)
XOM   104.30 (-1.46%)
NYSE:EHAB

Enhabit (EHAB) Stock Price, News & Analysis

$8.38
-0.43 (-4.88%)
(As of 01:15 PM ET)
Today's Range
$8.25
$8.81
50-Day Range
$8.80
$10.83
52-Week Range
$7.12
$14.77
Volume
321,085 shs
Average Volume
498,609 shs
Market Capitalization
$420.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.80

Enhabit MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.60 Rating Score
Upside/​Downside
45.3% Upside
$12.80 Price Target
Short Interest
Bearish
11.05% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.59mentions of Enhabit in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-11.11%
From $0.18 to $0.16 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.49 out of 5 stars

Medical Sector

890th out of 948 stocks

Home Health Care Services Industry

6th out of 7 stocks


EHAB stock logo

About Enhabit Stock (NYSE:EHAB)

Enhabit, Inc. is a leading healthcare provider that offers Medicare-certified skilled home health and hospice services in the United States. The company operates in two segments: Home Health and Hospice, providing services to adult patients needing care, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. Enhabit's hospice services include in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and emotional and spiritual support.

Enhabit operates home health agencies in approximately 34 states, with a concentration in the southern half of the United States. As of March 31, 2022, Enhabit operates in 252 home health agencies and 99 hospice agencies across 34 states. Enhabit provides practices to treat chronic diseases and conditions, including diabetes, arthritis, hypertension,  Alzheimer's disease, spinal stenosis, low vision,  Parkinson's disease, complex wound care, osteoporosis, and chronic pain, along with disease-specific plans for patients with diabetes, post-orthopedic surgery or injury, congestive heart failure,  and respiratory diseases.

Enhabit started as HealthSouth, founded in 1984 by Beam Scrushy and Richard Scrushy. In the early 2000s, the company restructured and rebranded into Encompass Health after being caught up in an accounting scandal. In Q2 of 2022, Enhabit, the healthcare and hospice division, became an independent public company, having completed its spinoff from Encompass Health Corporation. 

Barb Jacobsmeyer was named President and CEO of Enhabit Home Health & Hospice in June 2021. Jacobsmeyer came to Enhabit from Encompass Health, where she served as the company's executive vice president of operations. 

In Q3 of 2022, Enhabit, Inc. announced the acquisition of Caring Hearts Hospice, a locally-owned hospice agency in Texas. The acquisition adds four hospice locations in Texas to Enhabit's existing presence in the state. Ehnabit continues to expand, setting aside approximately one hundred million dollars to fund future mergers and acquisitions. 

Enhabit, Inc. is committed to providing high-quality care and service to patients and their families, and its success is a testament to its dedicated team of healthcare professionals. Enhabit is well-positioned to meet the growing demand for healthcare services in the United States as a leading home health and hospice service provider. With its focus on patient care and commitment to excellence, Enhabit is poised to continue to grow and succeed in the years ahead.

Enhabit's commitment to quality care has not gone unnoticed, as they have received numerous awards and recognitions for their services. In 2021, they were named a HomeCare Elite Top Agency for the 15th year. This recognition is given to the top-performing home health agencies in the United States. They have also received a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for their home health services, indicating their high quality and patient satisfaction.

Enhabit's success can be attributed to its skilled and compassionate staff and dedication to providing comprehensive and individualized patient care. Enhabit also recognizes the importance of emotional and spiritual support for their patients and their families, particularly in hospice care. Their hospice services include pain and symptom management, spiritual counseling, palliative and dietary counseling, social worker visits, and bereavement counseling services to meet terminally ill patients and their families' individual physical, spiritual, emotional, and psychosocial needs.

EHAB Stock Price History

EHAB Stock News Headlines

Enhabit (EHAB) to Release Quarterly Earnings on Wednesday
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Enhabit, Inc. (NYSE:EHAB) Q3 2023 Earnings Call Transcript
Q3 2023 Enhabit Inc Earnings Call
Enhabit (EHAB) Lags Q3 Earnings and Revenue Estimates
Enhabit Reports Third Quarter 2023 Financial Results
Enhabit Inc Shs EHAB
Why Shares of Enhabit Slumped on Tuesday
Goldman Sachs Sticks to Its Hold Rating for Enhabit, Inc (EHAB)
Calculating The Fair Value Of Enhabit, Inc. (NYSE:EHAB)
See More Headlines
Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/04/2024
Next Earnings (Confirmed)
3/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Fax
N/A
Employees
11,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.80
High Stock Price Target
$15.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+52.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.60
Research Coverage
5 Analysts

Profitability

Net Income
$-40,400,000.00
Pretax Margin
-17.23%

Debt

Sales & Book Value

Annual Sales
$1.08 billion
Cash Flow
$4.17 per share
Book Value
$15.52 per share

Miscellaneous

Free Float
49,178,000
Market Cap
$420.09 million
Optionable
Optionable
Beta
1.86
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Ms. Barbara Ann Jacobsmeyer B.S. (Age 58)
    M.A., P.T., President, CEO & Director
    Comp: $1.26M
  • Ms. Crissy Buchanan Carlisle (Age 52)
    Executive VP & CFO
    Comp: $611.66k
  • Ms. Tanya R. Marion (Age 50)
    Chief Human Resources Officer
    Comp: $445.86k
  • Ms. Julie Diane Jolley B.S.N. (Age 52)
    R.N., Executive Vice President of Home Health & Hospice Operations
    Comp: $642.65k
  • Ms. Jeanne Kalvaitis B.S.N. (Age 67)
    R.N., Executive Vice President of Hospice Operations
    Comp: $288.38k
  • Mark Brewer
    Chief Investor Relations Officer
  • Mr. Dylan C. Black (Age 55)
    General Counsel & Secretary
  • Mr. Ronald L. Langham Jr. (Age 47)
    M.B.A., P.T., Executive Vice President of Clinical Excellence & Strategy














EHAB Stock Analysis - Frequently Asked Questions

Should I buy or sell Enhabit stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Enhabit in the last year. There are currently 2 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" EHAB shares.
View EHAB analyst ratings
or view top-rated stocks.

What is Enhabit's stock price target for 2024?

5 brokers have issued 12-month price objectives for Enhabit's stock. Their EHAB share price targets range from $10.00 to $15.00. On average, they anticipate the company's share price to reach $12.80 in the next twelve months. This suggests a possible upside of 45.3% from the stock's current price.
View analysts price targets for EHAB
or view top-rated stocks among Wall Street analysts.

How have EHAB shares performed in 2024?

Enhabit's stock was trading at $10.35 at the beginning of the year. Since then, EHAB shares have decreased by 14.9% and is now trading at $8.81.
View the best growth stocks for 2024 here
.

Are investors shorting Enhabit?

Enhabit saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 4,880,000 shares, an increase of 11.2% from the January 31st total of 4,390,000 shares. Based on an average daily volume of 484,400 shares, the days-to-cover ratio is currently 10.1 days. Currently, 11.1% of the company's shares are sold short.
View Enhabit's Short Interest
.

When is Enhabit's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 6th 2024.
View our EHAB earnings forecast
.

How can I listen to Enhabit's earnings call?

Enhabit will be holding an earnings conference call on Thursday, March 7th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Who are Enhabit's major shareholders?

Enhabit's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.38%), Van Lanschot Kempen Investment Management N.V. (4.40%), Paradice Investment Management LLC (4.00%), Dimensional Fund Advisors LP (3.72%), UBS Group AG (3.32%) and Schroder Investment Management Group (2.72%). Insiders that own company stock include Barbara Ann Jacobsmeyer, Charles M Elson, Erin Hoeflinger, Gregory S Rush, Jeffrey Bolton, John E D D S Maupin Jr, L Edward Shaw Jr, Leo I Higdon Jr, Ronald Leroy Langham Jr and Tanya Renee Marion.
View institutional ownership trends
.

How do I buy shares of Enhabit?

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:EHAB) was last updated on 3/4/2024 by MarketBeat.com Staff